Information For Authors
- Manuscript Submission Guidelines
- Author Benefits Program
- Open Access Policy
- NIH/HHMI Wellcome Trust Policies
- Self-Archiving Policy
Lymphatic Research and Biology is a quarterly, peer-reviewed journal which will provide an interdisciplinary forum for the world’s leading biomedical investigators to discuss current and anticipated developments in lymphatic biology and pathology.
The Journal features fundamental scientific research of relevance to the lymphatic system and publishes original work from a variety of investigative disciplines, including genetics, biochemistry and biophysics, cellular and molecular biology, physiology and pharmacology, anatomy, developmental biology, and pathology. The Journal also encourages the submission of state-of-the-art reviews in focus areas such as vasculogenesis and angiogenesis, the genetics of lymphatic disorders, muscle cell biology, interstitial signaling mechanisms, and others.
Each figure should be submitted in a separate TIFF or EPS file. (See below.) References must be part of the manuscript text and not embedded through a separate program, such as EndNote. Authors with questions should address them to the Editorial Office at (516) 625-9675 or by e-mail to firstname.lastname@example.org
All submitting authors are required to complete their submissions using an ORCID identifier. Please visit the ORCID website for more information, or to register.
Manuscripts must be submitted online using the following URL:
Submissions should be formatted in Word. The main text file of the manuscript must include a title page, abstract, disclosure statement(s), and reference section. Figures, legends, and tables should not be embedded in the text. See below for more instructions.
Authors will be required to submit the names of three potential reviewers and their email addresses when submitting their papers.
1. Manuscripts should be prepared in Microsoft Word. Manuscripts should be double-spaced. Number the pages, including the title page. Leave 1-inch margins on all sides. Do not use justified margins.
2. Cite references, figures, and tables in numeric order. If any material has been published previously (figures, tables, etc), provide written permission from the copyright holder to use such material.
3. Consult the American Medical Association Manual of Style, 9th ed, Baltimore, MD, Williams; Wilkins, 1998, for style.
4. Assemble the manuscript in this order: Title page, abstracts, text, acknowledgments, references, figure legends, tables, and figures.
5. The title page (page 1) should contain these elements: Full title. Running title (not to exceed 50 characters,including spaces). Authors' names, academic degrees, and affiliations. Name and complete address for correspondence (include street name and address as well as PO box) and address for reprints if different from correspondence. Fax number, telephone number, and E-mail address. Sources of support that require acknowledgment.
Please supply a structured abstract of not more than 250 words, which should be self-explanatory without reference to the text. Do not cite references in the abstract. Limit use of acronyms and abbreviations. Define at first use with acronym or abbreviation in parentheses. Use the following headings: Background (rationale for study), Methods and Results (brief presentation of methods and presentation of significant results; note that both categories are included under one heading), and Conclusions (succinct statement of data interpretation). Include a condensed abstract of not more than 100 words for use in the annotated table of contents. It need not adhere to the structured format.
The body of the manuscript should consist of the following sections in this order: 1) Introduction, 2) Materials and Methods, 3) Results, 4) Conclusions.
Ethical Considerations in the Conduct and Reporting of Research:
Protection of Human Subjects and Animals in Research
When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should indicate whether the institutional and national guide for the care and use of laboratory animals was followed.
*This portion of the Instructions for Authors has been quoted directly from the Uniform Requirements for Manuscripts Submitted to Biomedical Journals website. For more information, visit www.icmje.org/ethical_6protection.html
Tables and Illustrations
Prepare each table with its title on a separate page in Microsoft word. Each table must stand alone and contain all necessary information in the legend. The table itself must be comprehensible independently from the text. Details of experimental conditions should be included in the table footnotes. Information that appears in the text should not be repeated in a table, and tables should not contain data that can be supplied within one or two sentences in the text.
Figures must be submitted as either TIFF or EPS files and labeled as Figure 1, Figure 2 and so on. Color figures and halftones must be at a minimum 300 DPI resolution.
Color must be saved as CYMK. Black and white line drawings must be at a minimum 1200 DPI resolution.
A list of figure legends should be supplied at the end of the manuscript, double-spaced in Microsoft word. Magnifications should be included when appropriate. Illustrations can be printed in color with a subsidy from the author and are encouraged. Contact the publisher for details.
Immediately following the Acknowledgments section, include a section entitled “Author Disclosure Statement.” In this portion of the paper, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the paper is being reviewed and will not influence the editorial decision. Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at http://www.icmje.org/index.html#conflicts for further guidance.
If no conflicts exist, the authors must state “No competing financial interests exist."
When naming your figure files, please label them with your manuscript number, followed by a period (.), and then list the figure number. Ex: MET-2008-0123.Fig1. Label figures and tables inside the files in addition to naming the file with the figure or table number. (ie: When figures or table files are opened, the figure or table number should appear inside the file.)
Please upload individual files of all manuscript material — do NOT upload a single PDF file containing all text, figure, and table files of your paper. Once all individual files are uploaded on to Manuscript Central, the system will automatically create a single PDF proof for you and the peer-review process.
If no conflicts exist, the authors must state “No competing financial interests exist."
References should be presented using the order of citation method. Please place a numerical superior in the text that corresponds to the number in the reference list. Below are examples of references in the reference list:
Jeltsch M., Kaipainen A., Joukov V., Meng X., Lakso M., Rauvala H., Swartz M., Fukumura D., Jain R.K., Alitalo K., Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science. 1997; 276: 1423-5
Book chapters Ferrara N., Gerber H., The Vascular Endothelial Growth Factor Family. In: Ware J.A., Simons M. eds. Angiogenesis and Cardiovascular Disease. New York: Oxford University Press; 1999: 101-27.
Please list each author’s name in the citation. If it is necessary to cite an abstract, this should be designated. Abbreviations of journal titles should follow Medline. Authors are responsible for the accuracy of the reference. Only works referred to in the text and already accepted for publication can be included.
The author must obtain permission to reproduce figures, tables, and text from previously published material. Written permission must be obtained from the original copyright holder (generally the publisher, not the author or editor) of the journal or book concerned. An appropriate credit line should be included in the figure or legend or table footnote, and full publication information should be included in the reference list. Written permission must be obtained from the author of any unpublished material and should accompany the manuscript.
Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.
Lymphatic Research and Biology is published by Mary Ann Liebert, Inc., publishers, 140 Huguenot Street, New Rochelle, NY 10801-5215. Telephone: (914) 740–2100; fax: (914) 740–2101.; E-mail: email@example.com
Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) option
Does your research funder have an open access mandate or would you like to expand the dissemination of your research?
The Liebert Open Access option enables authors to publish open access in our esteemed subscription-based journals.
The benefits of Liebert Open Access include:
- High visibility; open access articles are freely available online upon publication
- You retain copyright with the open access license allowing broad dissemination of your research
- You can freely share your article in repositories and research networks without restrictions
- Easy compliance with open access mandates
- Rigorous editorial and peer-review
- Targeted email announcement featuring a direct link to article
Identification and Marketing
Open access articles are listed with an OA icon in journal tables of content (TOC), TOC alerts, and in marketing announcements. Open access articles are highlighted and promoted in targeted email announcements to thousands of research leaders in your field.
Copyright and Licensing
If you choose to publish with open access, you will retain copyright of your article and a Creative Commons license will be applied. The liberal Creative Commons Attribution 4.0 (CC-BY) license is the default open access license used at Mary Ann Liebert, Inc., publishers. The CC-BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
Ordering Open Access
Once your article has been accepted for publication in a journal, you will receive an email with information on ordering Liebert Open Access. If you would like more information about Liebert Open Access or would like to order open access, please email firstname.lastname@example.org.
Publishing open access includes an article publication charge (APC) and authors are asked to fill out a short open access order form. You can pay by credit card or receive an invoice to be returned with payment or via bank transfer. Please remember that traditional subscription journals can carry mandatory or optional author fees. The Liebert Open Access APC does not cover or replace existing publication or author fees.
Publishing biomedical or biotechnology research?
Biomedical researchers should consider publishing in BioResearch Open Access, a fully open access peer-reviewed journal dedicated to publishing top research in the biomedical and biotechnology fields. For details, please visit the information for authors on the journal website.
*Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.
Browse journals in the Liebert Open Access portfolio:
NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.
Publishing in Subscription Journals
By signing the copyright transfer statement, authors still retain a set of rights that allow for self-archiving.
Authors may archive their preprint manuscripts (version prior to peer review) at any time without restrictions. Authors may archive their postprint manuscripts (accepted version after peer review) in institutional repositories, preprint servers, and research networks after a 12 month embargo. The 12 month embargo period begins when the article is published online. Postprints must not be used for commercial purposes and acknowledgement must be given to the final publication, and publisher, by inserting the DOI number of the article in the following sentence: “Final publication is available from Mary Ann Liebert, Inc., publishers http://dx.doi.org/[insert DOI]”. Authors may archive on their personal website without an embargo provided their manuscript is updated with an acknowledgement to the publisher copyright and final published version.
The final published article (version of record) can never be archived in a repository, preprint server, or research network.
Publishing Open Access
Authors that wish to easily comply with funder or institutional open access mandates should consider publishing open access. Liebert Open Access option allows authors to make their research freely available online without restrictions. Additionally, Liebert Open Access option allows authors to retain copyright, archive and share the final published version of their article without restrictions. To publish open access please email email@example.com or visit Liebert Open Access for more information.